A new report from Biopharma Dive, however, explains those studies have been halted "due to low enrollment."
The two companies, both of whom produced and sold the COVID-19 shots for billions of dollars during the pandemic that killed millions around the globe, confirmed they are halting a government-ordered post-marketing study "because of recruitment issues that, in turn, have impaired data collection."
No comments:
Post a Comment